Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practiceKirsten A. Nyrop, Hyman B. Muss, JoEllen C. Speca et al.|Cancer|2019Cited by 100
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast CancerKirsten A. Nyrop, Hyman B. Muss, Allison M. Deal et al.|The Oncologist|2018Cited by 94
Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancerKirsten A. Nyrop, Hyman B. Muss, Allison M. Deal et al.|Breast Cancer Research and Treatment|2017Cited by 62
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastasesAmanda E.D. Van Swearingen, Carey K. Anders, Marni B. Siegel et al.|Breast Cancer Research and Treatment|2018Cited by 48
Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, <i>p16INK4a</i>Shlomit Strulov Shachar, Hyman B. Muss, Allison M. Deal et al.|JNCI Cancer Spectrum|2020Cited by 33